Nabla's software, launched in March 2023, has over 20,000 users, with a significant contract win from the Permanente Medical Group. The company plans to launch services to help clinics generate billing codes for insurance companies and expand its language translation capabilities. Nabla's approach to data privacy involves storing all transcripts and visit summaries locally on the doctor's computer, ensuring no customer data is stored or used to retrain its models.
Key takeaways:
- Nabla, a health tech startup, has decided to break its reliance on OpenAI's GPT-3 and GPT-4 models due to their limitations and lack of control, and will instead focus on fine-tuning open source models like Facebook’s LLaMA 2 and those from startup Mistral.
- The company has developed a tool called Copilot, which uses AI to save doctors' time on administrative tasks by recording conversations with patients and automatically generating clinical notes required for medical documentation and billing.
- Nabla has raised $24 million in Series B funding, bringing its total funding to $43 million since its founding in 2018, and is valued at around $180 million post-money. The company plans to close a second tranche of around $10 million in funding by the end of February.
- Nabla's medical note-taking software, released in March 2023, has over 20,000 users, and the company plans to launch services that help clinics automatically generate the codes needed to bill insurance companies for particular medical services.